Extended panels (on request)

Cardiovascular risk panel

Thrombosis and lipid-related polymorphisms

Clinical area
Extended panels (on request)
Method
Variant panel
Sample
EDTA whole blood · Extracted DNA
Report languages
EN · AR · RU

About this test

Multi-marker panel in two parts. CVD1 covers Factor V Leiden, prothrombin G20210A, MTHFR C677T and A1298C, Factor XIII V34L and PAI-1. CVD2 covers APOE (E2/E4), APOB R3500Q, ACE I/D, LTA 804C>A, FGB -455G>A and HPA-1 (L33P). Results describe genotypes; most markers have modest or uncertain clinical effect.

When to order

When a clinician requests a broad genotype profile, for example in preventive or check-up programmes. It does not replace standard lipid and cardiovascular risk assessment.

Available assays

  • CVD1 + CVD2 panelSanger sequencing
  • CVD panelSanger sequencing
  • CVD total panelSanger sequencing

Offered on request. Current guidelines give this test a limited role in routine practice; results are reported as genotype or expression data for the ordering clinician to interpret.

Results are reported to the ordering physician and should be interpreted in clinical context.

Request this test

Offer this test to your patients.

Contract pricing and turnaround times are provided on request for laboratories and clinics.